Bright Minds Biosciences (NASDAQ:DRUG – Get Free Report) was downgraded by equities researchers at Wall Street Zen from a “hold” rating to a “sell” rating in a report issued on Saturday, Wall Street Zen reports. Other research analysts also recently issued reports about the company. Zacks Research downgraded Bright Minds Biosciences from a “strong-buy” rating […]

Plug Power (NASDAQ:PLUG – Get Free Report) was downgraded by investment analysts at Wall Street Zen from a “sell” rating to a “strong sell” rating in a note issued to investors on Saturday, Wall Street Zen reports. A number of other brokerages have also recently commented on PLUG. Roth Capital restated a “buy” rating and […]

Quantum-Si (NASDAQ:QSI – Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a note issued to investors on Saturday, Wall Street Zen reports. Several other equities research analysts have also recently commented on QSI. Weiss Ratings raised shares of Quantum-Si from a […]

BlossomHill Therapeutics (NASDAQ:BLSM – Get Free Report) was downgraded by research analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research note issued to investors on Saturday, Wall Street Zen reports. Several other research firms have also issued reports on BLSM. Lifesci Capital started coverage on BlossomHill Therapeutics in […]

Commerce Bancshares (NASDAQ:CBSH – Get Free Report) was downgraded by investment analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Saturday, Wall Street Zen reports. A number of other equities analysts also recently issued reports on the company. TD Cowen reiterated […]

Tonix Pharmaceuticals (NASDAQ:TNXP – Get Free Report) was downgraded by research analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a report issued on Saturday, Wall Street Zen reports. A number of other research analysts have also weighed in on the stock. Raymond James Financial reissued a “strong-buy” rating and […]

Kelly Services (NASDAQ:KELYA – Get Free Report) was downgraded by research analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued to investors on Saturday, Wall Street Zen reports. A number of other brokerages have also commented on KELYA. Barrington Research lifted their price target on shares […]

Cue Biopharma (NASDAQ:CUE – Get Free Report) was downgraded by analysts at Wall Street Zen from a “sell” rating to a “strong sell” rating in a note issued to investors on Saturday, Wall Street Zen reports. Other equities research analysts have also issued reports about the stock. Weiss Ratings lowered shares of Cue Biopharma from […]

Turn Therapeutics (NASDAQ:TTRX – Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research note issued on Saturday, Wall Street Zen reports. Other equities research analysts have also issued reports about the stock. WBB Securities reaffirmed a “sell” rating and set […]

Royalty Pharma (NASDAQ:RPRX – Get Free Report) was downgraded by investment analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research note issued to investors on Saturday, Wall Street Zen reports. A number of other analysts have also recently issued reports on the company. Weiss Ratings raised Royalty Pharma […]

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) was downgraded by investment analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a report issued on Sunday, Wall Street Zen reports. ISRG has been the subject of a number of other reports. Royal Bank Of Canada dropped their price objective on Intuitive […]

Upexi (NASDAQ:UPXI – Get Free Report) was downgraded by investment analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a report issued on Sunday, Wall Street Zen reports. A number of other research firms have also recently issued reports on UPXI. Weiss Ratings reaffirmed a “sell (e+)” rating on shares […]